Value Framework ICER has developed and updated a Value Assessment Framework to define the benefits and prices of health interventions. This creates a clear opportunity to offer market access services, value dossier development, pricing strategy aligned with payer expectations, and training on the framework for pharma and medical device teams.

Collaborative Engagement ICER works with patients, clinical experts, and stakeholders to inform evidence generation. This suggests opportunities to partner on patient-reported outcomes data collection, stakeholder mapping, and co-created evidence programs, plus services to support dissemination of HTA findings.

Advanced Therapy Focus ICER regularly reviews advanced therapies including gene therapies and neurodegenerative drugs, signaling demand for rapid evidence synthesis, post-launch monitoring, and comparative effectiveness analyses. Opportunities to provide rapid review sprints, post-market data pipelines, real-world evidence integrations, and benchmarking for biotech products.

Pricing & Access ICER’s mission is to measure value and suggest fair prices while reporting barriers to care. This points to opportunities for ongoing pricing intelligence, access analytics, payer mapping, and subscription-based updates to value datasets and HTA-ready materials.

Tech & Outreach ICER employs modern tech like iCIMS, Zendesk, and marketing tools to run operations and outreach. This indicates potential for services in digital experience optimization, marketing automation, data-driven content delivery, and secure data sharing or dashboards for HTA outputs, sponsorships of reports or events.